Health Catalyst (HCAT) Short Interest Ratio & Short Volume → What President Biden's new law means for investors (From Stansberry Research) (Ad) Free HCAT Stock Alerts $6.79 -0.13 (-1.88%) (As of 11:15 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Health Catalyst Short Interest DataCurrent Short Interest1,930,000 sharesPrevious Short Interest1,760,000 sharesChange Vs. Previous Month+9.66%Dollar Volume Sold Short$12.00 millionShort Interest Ratio2.9 Days to CoverLast Record DateApril 30, 2024Outstanding Shares59,030,000 sharesPercentage of Shares Shorted3.27%Today's Trading Volume35,213 sharesAverage Trading Volume631,258 sharesToday's Volume Vs. Average6% Short Selling Health Catalyst ? Sign up to receive the latest short interest report for Health Catalyst and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHCAT Short Interest Over TimeHCAT Days to Cover Over TimeHCAT Percentage of Float Shorted Over Time Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Health Catalyst Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,930,000 shares $12.00 million +9.7%N/A2.9 $6.22 4/15/20241,760,000 shares $9.98 million +15.8%N/A2.9 $5.67 3/31/20241,520,000 shares $11.45 million -16.5%N/A2.5 $7.53 3/15/20241,820,000 shares $14.23 million +6.4%N/A3.1 $7.82 2/29/20241,710,000 shares $14.23 million +19.6%N/A2.7 $8.32 2/15/20241,430,000 shares $14.34 million -4.7%N/A2.5 $10.03 Get the Latest News and Ratings for HCAT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,500,000 shares $14.66 million -15.7%N/A2.7 $9.77 1/15/20241,780,000 shares $19.56 million +17.9%N/A3.2 $10.99 12/31/20231,510,000 shares $13.98 million -2.6%N/A2.9 $9.26 12/15/20231,550,000 shares $13.56 million -4.9%N/A2.9 $8.75 11/30/20231,630,000 shares $11.70 million -5.2%N/A3.4 $7.18 11/15/20231,720,000 shares $13.79 million +13.9%N/A3.7 $8.02 10/31/20231,510,000 shares $11.31 million +16.2%N/A3.5 $7.49 10/15/20231,300,000 shares $10.86 million +30.8%N/A3.2 $8.35 9/30/2023993,800 shares $10.06 million -2.6%N/A2.6 $10.12 9/15/20231,020,000 shares $10.62 million -1.9%N/A2.8 $10.41 8/31/20231,040,000 shares $12.16 million -4.6%N/A2.7 $11.69 8/15/20231,090,000 shares $13.84 million -1.8%N/A2.8 $12.70 7/31/20231,110,000 shares $15.57 million -9.8%N/A2.5 $14.03 7/15/20231,230,000 shares $15.13 million +1.7%N/A2.9 $12.30 6/30/20231,210,000 shares $15.13 million -13.0%N/A2.7 $12.50 6/15/20231,390,000 shares $17.28 million -8.6%N/A3 $12.43 5/31/20231,520,000 shares $17.12 million -14.6%N/A3.3 $11.26 5/15/20231,780,000 shares $19.78 million +2.3%N/A3.5 $11.11 4/30/20231,740,000 shares $21.92 million -5.4%N/A3.7 $12.60 4/15/20231,840,000 shares $23.72 million -1.1%N/A3.4 $12.89 3/31/20231,860,000 shares $21.71 million -13.5%N/A3.3 $11.67 3/15/20232,150,000 shares $25.76 million +8.0%N/A3.7 $11.98 2/28/20231,990,000 shares $27.78 million -2.5%N/A3.4 $13.96 2/15/20232,040,000 shares $29.46 million +13.3%N/A3.5 $14.44 1/31/20231,800,000 shares $25.02 million -8.6%N/A2.4 $13.90 1/15/20231,970,000 shares $23.88 million +18.7%N/A2.4 $12.12 12/30/20221,660,000 shares $17.65 million +2.5%N/A2.1 $10.63 12/15/20221,620,000 shares $17.14 million -13.4%N/A1.9 $10.58 11/30/20221,870,000 shares $19.60 million -12.6%N/A1.9 $10.48 11/15/20222,140,000 shares $23.37 million -13.0%N/A2 $10.92 10/31/20222,460,000 shares $21.70 million -10.6%N/A2.4 $8.82 10/15/20222,750,000 shares $23.73 million -6.1%N/A2.4 $8.63 9/30/20222,930,000 shares $28.42 million +15.8%N/A2.5 $9.70 9/15/20222,530,000 shares $27.65 million -21.2%N/A2.1 $10.93Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. 8/31/20223,210,000 shares $38.52 million +1.3%N/A2.6 $12.00 8/15/20223,170,000 shares $42.92 million -15.0%N/A2.8 $13.54 7/31/20223,730,000 shares $62.44 million -7.4%N/A3.2 $16.74 7/15/20224,030,000 shares $64.88 million -2.4%N/A3.9 $16.10 6/30/20224,130,000 shares $59.84 million +4.3%N/A4 $14.49 6/15/20223,960,000 shares $49.46 million +14.8%N/A4 $12.49 5/31/20223,450,000 shares $50.54 million -5.7%N/A3.9 $14.65 5/15/20223,660,000 shares $59.04 million +6.4%N/A4.2 $16.13 4/30/20223,440,000 shares $57.24 million -4.7%N/A4.5 $16.64 4/15/20223,610,000 shares $85.95 million -0.6%N/A5.8 $23.81 3/31/20223,630,000 shares $94.85 million -11.9%N/A6.1 $26.13 3/15/20224,120,000 shares $88.04 million -4.9%N/A7.2 $21.37 2/28/20224,330,000 shares $117.43 million +2.1%N/A7.9 $27.12 2/15/20224,240,000 shares $126.01 million -10.2%N/A8.2 $29.72 1/31/20224,720,000 shares $140.89 million -6.4%N/A9.1 $29.85 1/15/20225,040,000 shares $161.58 million -7.2%N/A10.6 $32.06 12/31/20215,430,000 shares $215.14 million +15.5%N/A12.2 $39.62 12/15/20214,700,000 shares $177.52 million +0.4%N/A10.9 $37.77 11/30/20214,680,000 shares $203.07 million -5.3%N/A11 $43.39 11/15/20214,940,000 shares $244.58 million -4.1%N/A12 $49.51 10/29/20215,150,000 shares $271.10 million -2.7%N/A11.7 $52.64 10/15/20215,290,000 shares $256.09 million +9.5%N/A12.6 $48.41 9/30/20214,830,000 shares $241.55 million -2.8%N/A11.7 $50.01 9/15/20214,970,000 shares $268.78 million -2.2%N/A12.3 $54.08 8/31/20215,080,000 shares $277.42 million -3.4%N/A13.1 $54.61 8/13/20215,260,000 shares $275.99 million -4.9%N/A12.9 $52.47 7/30/20215,530,000 shares $321.07 million +4.5%13.2%14.4 $58.06 7/15/20215,290,000 shares $289.52 million -1.5%12.6%11.8 $54.73 6/30/20215,370,000 shares $298.09 million -4.1%12.8%11.1 $55.51 6/15/20215,600,000 shares $313.82 million -2.4%13.3%12.2 $56.04 5/28/20215,740,000 shares $308.18 million +2.1%13.6%12.8 $53.69 5/14/20215,620,000 shares $270.10 million +9.1%N/A11.4 $48.06 4/30/20215,150,000 shares $298.80 million +0.4%N/A10.1 $58.02 4/15/20215,130,000 shares $259.22 million -10.6%N/A11.2 $50.53 3/31/20215,740,000 shares $265.65 million +0.5%N/A12.9 $46.28 3/15/20215,710,000 shares $276.42 million +5.7%N/A12.4 $48.41 2/26/20215,400,000 shares $252.99 million -6.1%N/A10.3 $46.85 2/12/20215,750,000 shares $309.93 million -5.1%16.4%12.1 $53.90 1/29/20216,060,000 shares $309.73 million +3.1%18.2%13.3 $51.11 1/15/20215,880,000 shares $281.30 million -4.2%17.7%13 $47.84 12/31/20206,140,000 shares $265.56 million +4.1%18.4%14.1 $43.25 12/15/20205,900,000 shares $227.68 million -7.2%17.7%13.3 $38.59 11/30/20206,360,000 shares $229.21 million -0.6%19.1%13 $36.04 11/15/20206,400,000 shares $220.80 million -1.4%19.6%13 $34.50 10/30/20206,490,000 shares $223.78 million -1.8%20.9%12.1 $34.48 10/15/20206,610,000 shares $234.06 million -7.7%21.3%11.6 $35.41 9/30/20207,160,000 shares $262.06 million +6.6%24.4%10.9 $36.60 9/15/20206,720,000 shares $240.11 million +0.8%22.9%9.3 $35.73 8/31/20206,670,000 shares $207.97 million -2.6%22.7%9.2 $31.18 8/14/20206,850,000 shares $214.61 million -1.9%23.4%9.8 $31.33Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. 7/31/20206,980,000 shares $243.60 million -3.3%28.4%9.6 $34.90 7/15/20207,220,000 shares $245.41 million +2.6%29.4%9.5 $33.99 6/30/20207,040,000 shares $194.30 million +11.8%30.2%7.9 $27.60 6/15/20206,300,000 shares $184.02 million +4.7%26.8%7.5 $29.21 5/29/20206,020,000 shares $163.38 million +5.8%25.5%7.4 $27.14 5/15/20205,690,000 shares $163.13 million +14.0%24.4%6.5 $28.67 4/30/20204,990,000 shares $133.08 million +7.1%22.4%6.4 $26.67 4/15/20204,660,000 shares $122.46 million +82.0%20.9%6.4 $26.28 3/31/20202,560,000 shares $66.89 million -0.3%11.5%4.6 $26.13 3/13/20202,566,900 shares $64.28 million -14.7%11.7%3.5 $25.04 2/28/20203,010,000 shares $71.61 million +6.4%13.7%8.1 $23.79 2/14/20202,830,000 shares $78.59 million +1.8%14.0%10.3 $27.77 1/31/20202,780,000 shares $83.40 million +10.8%15.0%10.9 $30.00 1/15/20202,510,000 shares $82.35 million +7.7%14.0%11.3 $32.81 12/31/20192,330,000 shares $81.48 million +11.0%13.9%11.1 $34.97 HCAT Short Interest - Frequently Asked Questions What is Health Catalyst's current short interest? Short interest is the volume of Health Catalyst shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,930,000 shares of HCAT short. Learn More on Health Catalyst's current short interest. What is a good short interest ratio for Health Catalyst? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HCAT shares currently have a short interest ratio of 3.0. Learn More on Health Catalyst's short interest ratio. Is Health Catalyst's short interest increasing or decreasing? Health Catalyst saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,930,000 shares, an increase of 9.7% from the previous total of 1,760,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Health Catalyst's short interest compare to its competitors? Here is how the short interest of companies compare to Health Catalyst: Shattuck Labs, Inc. (4.29%), OraSure Technologies, Inc. (5.07%), Verrica Pharmaceuticals Inc. (14.05%), Korro Bio, Inc. (2.68%), Neurogene Inc. (8.85%), Replimune Group, Inc. (19.05%), C4 Therapeutics, Inc. (14.74%), Esperion Therapeutics, Inc. (11.79%), Mereo BioPharma Group plc (2.02%), Terns Pharmaceuticals, Inc. (10.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Health Catalyst stock? Short selling HCAT is an investing strategy that aims to generate trading profit from Health Catalyst as its price is falling. HCAT shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Health Catalyst? A short squeeze for Health Catalyst occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HCAT, which in turn drives the price of the stock up even further. How often is Health Catalyst's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HCAT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: STTK Short Interest Data OSUR Short Interest Data VRCA Short Interest Data KRRO Short Interest Data NGNE Short Interest Data REPL Short Interest Data CCCC Short Interest Data ESPR Short Interest Data MREO Short Interest Data TERN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HCAT) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldNext President (Not Trump. Not Biden.)The Freeport Society